Pedro Fidalgo1, Mohammed Ahmed2, Steven R Meyer3, Dale Lien4, Justin Weinkauf3, Filipe S Cardoso5, Kathy Jackson6, Sean M Bagshaw2. 1. Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada Nephrology Department, Hospital Prof Dr Fernando Fonseca, Amadora, Portugal. 2. Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. 3. Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AB, Canada. 4. Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. 5. Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada Gastroenterology Department, Hospital Prof Dr Fernando Fonseca, Amadora, Portugal. 6. Lung Transplant Program, Alberta Health Services, Edmonton, AB, Canada.
Abstract
BACKGROUND: Acute kidney injury (AKI) is a serious complication following lung transplantation (LTx). We aimed to describe the incidence and outcomes associated with AKI following LTx. METHODS: A retrospective population-based cohort study of all adult recipients of LTx at the University of Alberta between 1990 and 2011. The primary outcome was AKI, defined and classified according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria, in the first 7 post-operative days. Secondary outcomes included risk factors, utilization of renal replacement therapy (RRT), occurrence of post-operative complications, mortality and kidney recovery. RESULTS: Of 445 LTx recipients included, AKI occurred in 306 (68.8%), with severity classified as Stage I in 38.9% (n = 173), Stage II in 17.5% (n = 78) and Stage III in 12.4% (n = 55). RRT was received by 36 (8.1%). Factors associated with AKI included longer duration of cardiopulmonary bypass [per minute, odds ratio (OR) 1.003; 95% confidence interval (CI), 1.001-1.006; P = 0.02], and mechanical ventilation [per hour (log-transformed), OR 5.30; 95% CI, 3.04-9.24; P < 0.001], and use of cyclosporine (OR 2.03; 95% CI, 1.13-3.64; P = 0.02). In-hospital and 1-year mortality were significantly higher in those with AKI compared with no AKI (7.2 versus 0%; adjusted P = 0.001; 14.4 versus 5.0%; adjusted P = 0.02, respectively). At 3 months, those with AKI had greater sustained loss of kidney function compared with no AKI [estimated glomerular filtration rate, mean (SD): 68.9 (25.7) versus 75.3 (22.1) mL/min/1.73 m(2), P = 0.01]. CONCLUSIONS: By the KDIGO definition, AKI occurred in two-thirds of patients following LTx. AKI portended greater risk of death and loss of kidney function.
BACKGROUND:Acute kidney injury (AKI) is a serious complication following lung transplantation (LTx). We aimed to describe the incidence and outcomes associated with AKI following LTx. METHODS: A retrospective population-based cohort study of all adult recipients of LTx at the University of Alberta between 1990 and 2011. The primary outcome was AKI, defined and classified according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria, in the first 7 post-operative days. Secondary outcomes included risk factors, utilization of renal replacement therapy (RRT), occurrence of post-operative complications, mortality and kidney recovery. RESULTS: Of 445 LTx recipients included, AKI occurred in 306 (68.8%), with severity classified as Stage I in 38.9% (n = 173), Stage II in 17.5% (n = 78) and Stage III in 12.4% (n = 55). RRT was received by 36 (8.1%). Factors associated with AKI included longer duration of cardiopulmonary bypass [per minute, odds ratio (OR) 1.003; 95% confidence interval (CI), 1.001-1.006; P = 0.02], and mechanical ventilation [per hour (log-transformed), OR 5.30; 95% CI, 3.04-9.24; P < 0.001], and use of cyclosporine (OR 2.03; 95% CI, 1.13-3.64; P = 0.02). In-hospital and 1-year mortality were significantly higher in those with AKI compared with no AKI (7.2 versus 0%; adjusted P = 0.001; 14.4 versus 5.0%; adjusted P = 0.02, respectively). At 3 months, those with AKI had greater sustained loss of kidney function compared with no AKI [estimated glomerular filtration rate, mean (SD): 68.9 (25.7) versus 75.3 (22.1) mL/min/1.73 m(2), P = 0.01]. CONCLUSIONS: By the KDIGO definition, AKI occurred in two-thirds of patients following LTx. AKI portended greater risk of death and loss of kidney function.
Authors: Christopher A Heid; Mitri K Khoury; Kayla Maaraoui; Charles Liu; Matthias Peltz; Michael A Wait; W Steves Ring; Lynn C Huffman Journal: J Surg Res Date: 2020-06-26 Impact factor: 2.192
Authors: Gregory L Hundemer; Anand Srivastava; Kirolos A Jacob; Neeraja Krishnasamudram; Salman Ahmed; Emily Boerger; Shreyak Sharma; Kapil K Pokharel; Sameer A Hirji; Marc Pelletier; Kassem Safa; Win Kulvichit; John A Kellum; Leonardo V Riella; David E Leaf Journal: Nephrol Dial Transplant Date: 2021-01-01 Impact factor: 5.992
Authors: Michael G S Shashaty; Caitlin M Forker; Todd A Miano; Qufei Wu; Wei Yang; Michelle L Oyster; Mary K Porteous; Edward E Cantu; Joshua M Diamond; Jason D Christie Journal: Clin Transplant Date: 2019-08-28 Impact factor: 2.863
Authors: Caitlin M Forker; Todd A Miano; John P Reilly; Michelle L Oyster; Mary K Porteous; Edward E Cantu; Lorraine B Ware; Joshua M Diamond; Jason D Christie; Michael G S Shashaty Journal: Am J Transplant Date: 2019-05-23 Impact factor: 8.086